These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Are mimotope vaccines a good alternative to monoclonal antibodies? Pourjafar M; Samadi P; Khoshinani HM; Saidijam M Immunotherapy; 2019 Jun; 11(9):795-800. PubMed ID: 31094256 [TBL] [Abstract][Full Text] [Related]
3. Construction and characterization of monoclonal antibodies against the extracellular domain of B-lymphocyte antigen CD20 using DNA immunization method. Khademi F; Mostafaie A; Parvaneh S; Gholami Rad F; Mohammadi P; Bahrami G Int Immunopharmacol; 2017 Feb; 43():23-32. PubMed ID: 27939822 [TBL] [Abstract][Full Text] [Related]
4. The emerging therapeutic role of antibody mixtures. Robak T Expert Opin Biol Ther; 2013 Jul; 13(7):953-8. PubMed ID: 23646883 [TBL] [Abstract][Full Text] [Related]
6. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases. Chin LT; Chu C; Chen HM; Wang DW; Liao SK Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049 [TBL] [Abstract][Full Text] [Related]
7. Editorial: Is the Recent Burst of Therapeutic Anti-tumor Antibodies the Tip of an Iceberg? Kremer L; Garcia-Sanz JA Front Immunol; 2018; 9():442. PubMed ID: 29556241 [No Abstract] [Full Text] [Related]
8. Stable, soluble, high-affinity, engineered T cell receptors: novel antibody-like proteins for specific targeting of peptide antigens. Boulter JM; Jakobsen BK Clin Exp Immunol; 2005 Dec; 142(3):454-60. PubMed ID: 16297157 [TBL] [Abstract][Full Text] [Related]
9. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
10. T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies. Chatenoud L; Bach JF Immunol Ser; 1993; 59():101-16. PubMed ID: 7681694 [No Abstract] [Full Text] [Related]
11. Monoclonal antibodies as therapeutics in oncology. Trikha M; Yan L; Nakada MT Curr Opin Biotechnol; 2002 Dec; 13(6):609-14. PubMed ID: 12482522 [TBL] [Abstract][Full Text] [Related]
12. Monoclonal antibodies based on hybridoma technology. Yagami H; Kato H; Tsumoto K; Tomita M Pharm Pat Anal; 2013 Mar; 2(2):249-63. PubMed ID: 24237029 [TBL] [Abstract][Full Text] [Related]
13. Engineering therapeutic monoclonal antibodies. Liu XY; Pop LM; Vitetta ES Immunol Rev; 2008 Apr; 222():9-27. PubMed ID: 18363992 [TBL] [Abstract][Full Text] [Related]
17. Conformation-specific monoclonal antibodies recognizing the native structure of G protein-coupled receptor (GPCR). Isozaki Y; Tsumoto K; Tomita M Int Immunopharmacol; 2021 Sep; 98():107872. PubMed ID: 34182241 [TBL] [Abstract][Full Text] [Related]
18. Delineation of B-cell Epitopes of Salmonella enterica serovar Typhi Hemolysin E: Potential antibody therapeutic target. Chin CF; Lai JY; Choong YS; Anthony AA; Ismail A; Lim TS Sci Rep; 2017 May; 7(1):2176. PubMed ID: 28526816 [TBL] [Abstract][Full Text] [Related]
19. Targeting B cells in treatment of autoimmunity. Franks SE; Getahun A; Hogarth PM; Cambier JC Curr Opin Immunol; 2016 Dec; 43():39-45. PubMed ID: 27718447 [TBL] [Abstract][Full Text] [Related]
20. Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy. Cho SF; Anderson KC; Tai YT Front Immunol; 2018; 9():1821. PubMed ID: 30147690 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]